Lebwohl, M., Bukhalo, M., Gold, L. S., Pelle, M., Glick, B., Llamas-Velasco, M., Sanchez-Rivera, S., Zhan, T., Drogaris, L., Douglas, K., St. John, G., Espaillat, R., & Bissonnette, R. (2023). A Phase 3b Study Evaluating Safety and Efficacy of Risankizumab in Adult Patients with Moderate-to-Severe Plaque Psoriasis with Palmoplantar (Non-Pustular) Involvement. SKIN The Journal of Cutaneous Medicine, 7(6), s256. https://doi.org/10.25251/skin.7.supp.256